Effect of combined sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonist therapy in patients with chronic kidney disease: a real-world analysis.
A recently indexed PubMed record relevant to peptide research. The displayed date may reflect indexing rather than final print publication. Review the original citation and study limitations.
Open original source ↗Collected Nov 2, 2026. Third-party data may change. Consult the original publication or registry for complete methods, findings and status.